Cargando...
Comparing and Combining Biomarkers as Principle Surrogates for Time-to-Event Clinical Endpoints
Principal surrogate endpoints are useful as targets for Phase I and II trials. In many recent trials, multiple post-randomization biomarkers are measured. However, few statistical methods exist for comparison of or combination of biomarkers as principal surrogates and none of these methods to our kn...
Gardado en:
| Publicado en: | Stat Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801510/ https://ncbi.nlm.nih.gov/pubmed/25352131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6349 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|